Trials / Completed
CompletedNCT00619710
Complicated Skin and Skin Structure Infections
A Multicenter, Randomized, Double Blind, Comparative Trial of Intravenous MERREM (Meropenem, ICI 194,660) vs PRIMAXIN I.V. (Imipenem-cilastatin) in the Treatment of Hospitalised Subjects With Complicated Skin and Skin Structure Infections.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,000 (estimated)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 13 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate the non-inferiority of meropenem (Merrem) and imipenem in hospitalised subjects with complicated skin and skin structure infections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Meropenem | Intravenous |
| DRUG | Imipenem-cilastatin | Intravenous |
Timeline
- Start date
- 2001-02-01
- Primary completion
- 2003-12-01
- Completion
- 2004-04-01
- First posted
- 2008-02-21
- Last updated
- 2017-09-01
Source: ClinicalTrials.gov record NCT00619710. Inclusion in this directory is not an endorsement.